Medical Condition

hiv

Total Trials

31

Recruiting Now

31

Trial Phases

Phase 2, Phase 1, Phase 4

ClinicalMetric tracks all active clinical trials for hiv sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — hiv Clinical Trials

How many clinical trials are currently recruiting for hiv?

ClinicalMetric currently tracks 31 actively recruiting clinical trials for hiv, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 31. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for hiv?

hiv research spans Phase 1 (3 trials), Phase 2 (4 trials), Phase 4 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a hiv clinical trial?

Eligibility criteria for hiv trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 4

Top Sponsors

Yale University 3 trials

Massachusetts General Hospital 3 trials

University of Alabama at Birmingham 2 trials

Boston University 2 trials

University of California, San Francisco 2 trials

hiv

Frequently Asked Questions — hiv Clinical Trials

Recruiting Clinical Trials

Assessing Peer Support for Physical Activity in Women With HIV and Hypertension

Sequential Analysis Before and After Treatment Initiation to Unravel the Role of Naturally Occurring Extracellular Vesicles in HIV Infection

#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.

Gathering Records to Evaluate Antiretroviral Treatment-South Africa

A Study to Improve Skeletal Muscle in Veterans With HIV

PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

A Behavioral mHealth Intervention for People With HIV With Anxiety and Depression

Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria

Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV

HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)

UNCPM 22322 - Adaption of the Transition of Care Model for Post-Discharge HIV-NCD Care in Lilongwe, Malawi - MLATHO

Post Analytic Treatment Interruption Study

1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV

IBIS Megastudy of Interventions to Encourage HIV Retesting

Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health

Gathering Records to Evaluate Antiretroviral Treatment-Zambia (GREAT )

Change My Story Task Shifted Mental Health Intervention

Multidisciplinary Low-Barrier and Mobile HIV Care to Improve Retention and Viral Suppression: Stakeholder-Engaged Design and Evaluation

A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and With HIV.

Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

HIV Prevention and Care Interventions for Youth in Uganda

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide

Behavioral and Psychosocial Characteristics of Clients Accessing Services at IHRI

B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIV

Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury

Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV

Peru Decentralized HIV Care

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

Predictors of Health Service Utilizations Among Key Population in Washington DC